• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两栖动物皮肤作为治疗性肽的来源]

[Amphibian skin as a source of therapeutic peptides].

作者信息

Amiche Mohamed

出版信息

Biol Aujourdhui. 2016;210(2):101-17. doi: 10.1051/jbio/2016015. Epub 2016 Sep 30.

DOI:10.1051/jbio/2016015
PMID:27687601
Abstract

The search for new bioactive molecules that could be used in therapeutics is a major public health issue, particularly in the treatment of certain diseases such as cancer. In this context the exploration of the venom of animals (snakes, amphibians, cones, scorpions, insects...) that produce molecules of various structures and biological activities, is a very promising direction. Research in this area led to the discovery of neuropeptides, hormones, toxins, antimicrobial peptides and other extremely potent mediators. These are now used in many areas both in fundamental research and in translational research, respectively, to understand biochemical and physiological mechanisms, or to use as medical diagnostic tools and for therapeutic purposes. Pr. V. Erspamer is the first researcher to have shown, in the 1930s, that in addition to biogenic amines and alkaloids, granular glands from the skin of amphibians also produced huge amounts of peptides with various structures and biological activities. He also showed that these peptides had their counterparts, most often in the form of identical or similar peptides, in the central nervous system and the gastrointestinal tract of mammals. These observations are summarized in the form of a triangle concept of "brain-gut-skin" that states that any peptide found in a compartment should be present in the other two. In addition, abundance, ease of extraction and identification of peptides from amphibian skin make this model a means to search for their counterparts in mammals where they are present in minute quantities. This approach has two advantages: (i) at the fundamental level, the large peptide diversity, ubiquity and multiplicity of functions to which they participate, constitute a true chemical library to understand the mechanisms of recognition and signal transduction and study the physicochemical basic of the specificity; and (ii) in terms of applications, the relative simplicity of these peptides and the rise of the production techniques by chemical or recombinant synthesis offer an innovative potential for the development of molecules with pharmacological or therapeutic purposes.

摘要

寻找可用于治疗的新型生物活性分子是一个重大的公共卫生问题,尤其是在治疗某些疾病(如癌症)方面。在这种背景下,探索产生具有各种结构和生物活性分子的动物毒液(蛇、两栖动物、芋螺、蝎子、昆虫等)是一个非常有前景的方向。该领域的研究导致了神经肽、激素、毒素、抗菌肽和其他极其有效的介质的发现。如今,这些物质分别在基础研究和转化研究的许多领域中得到应用,用于理解生化和生理机制,或用作医学诊断工具及治疗目的。V. 埃斯帕默教授是首位在20世纪30年代表明,除了生物胺和生物碱外,两栖动物皮肤的颗粒腺还能产生大量具有各种结构和生物活性的肽的研究人员。他还表明,这些肽在哺乳动物的中枢神经系统和胃肠道中也有对应物,且大多以相同或相似肽的形式存在。这些观察结果以“脑-肠-皮肤”三角概念的形式进行了总结,即任何在一个隔室中发现的肽都应存在于其他两个隔室中。此外,从两栖动物皮肤中提取和鉴定肽的丰富性、简便性,使得该模型成为在哺乳动物中寻找微量存在的对应物的一种手段。这种方法有两个优点:(i)在基础层面,肽的多样性大、普遍存在且参与多种功能,构成了一个真正的化学库,有助于理解识别和信号转导机制,并研究特异性的物理化学基础;(ii)在应用方面,这些肽相对简单,且化学或重组合成生产技术的兴起为开发具有药理或治疗目的的分子提供了创新潜力。

相似文献

1
[Amphibian skin as a source of therapeutic peptides].[两栖动物皮肤作为治疗性肽的来源]
Biol Aujourdhui. 2016;210(2):101-17. doi: 10.1051/jbio/2016015. Epub 2016 Sep 30.
2
The natural history of amphibian skin secretions, their normal functioning and potential medical applications.两栖动物皮肤分泌物的自然史、其正常功能及潜在医学应用。
Biol Rev Camb Philos Soc. 1997 Aug;72(3):365-79. doi: 10.1017/s0006323197005045.
3
[Amphibian skin secretions as a new source of antibiotics and biologically active substances].[两栖动物皮肤分泌物作为抗生素和生物活性物质的新来源]
Postepy Hig Med Dosw (Online). 2009 Nov 12;63:537-48.
4
Amphibian skin: a promising resource for antimicrobial peptides.两栖动物皮肤:抗菌肽的一个有前景的来源。
Trends Biotechnol. 1995 Jun;13(6):205-9. doi: 10.1016/S0167-7799(00)88947-7.
5
Comparative histochemistry as a springboard for the discovery of biogenic amines and active peptides in molluscan tissues and amphibian skin.比较组织化学作为发现软体动物组织和两栖动物皮肤中生物胺和活性肽的跳板。
Basic Appl Histochem. 1981;25(1):3-14.
6
Bioactive molecules from amphibian skin: their biological activities with reference to therapeutic potentials for possible drug development.来自两栖动物皮肤的生物活性分子:就可能的药物开发的治疗潜力而言,它们的生物活性
Indian J Exp Biol. 2007 Jul;45(7):579-93.
7
Half a century of comparative research on biogenic amines and active peptides in amphibian skin and molluscan tissues.对两栖动物皮肤和软体动物组织中的生物胺和活性肽进行半个世纪的比较研究。
Comp Biochem Physiol C Comp Pharmacol Toxicol. 1984;79(1):1-7. doi: 10.1016/0742-8413(84)90153-1.
8
The chemistry of poisons in amphibian skin.两栖动物皮肤中毒素的化学性质。
Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):9-13. doi: 10.1073/pnas.92.1.9.
9
Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.南美橙腿叶蛙(Phyllomedusa hypocondrialis)颗粒腺蛋白质组和转录组的成分在其风干的皮肤中依然存在。
Peptides. 2006 Sep;27(9):2129-36. doi: 10.1016/j.peptides.2006.04.006. Epub 2006 May 19.
10
Antimicrobial peptides from Phyllomedusa frogs: from biomolecular diversity to potential nanotechnologic medical applications.从 Phyllomedusa 青蛙中提取的抗菌肽:从生物分子多样性到潜在的纳米医学应用。
Amino Acids. 2011 Jan;40(1):29-49. doi: 10.1007/s00726-010-0622-3. Epub 2010 Jun 5.

引用本文的文献

1
Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs.爬行动物作为癌症治疗药物中药用天然产物的潜在来源。
Pharmaceutics. 2022 Apr 16;14(4):874. doi: 10.3390/pharmaceutics14040874.
2
Effect of Multiradiance Low-Level Laser Therapy and Topical Silver Sulfadiazine on Healing Characteristics of Dermal Wounds in Marine Toads ().多辐射低强度激光疗法和磺胺嘧啶银对海蟾蜍皮肤伤口愈合特性的影响()。 (括号内内容原文缺失)
Vet Med Int. 2020 Oct 17;2020:8888328. doi: 10.1155/2020/8888328. eCollection 2020.
3
Biofilms: Novel Strategies Based on Antimicrobial Peptides.
生物膜:基于抗菌肽的新策略。
Pharmaceutics. 2019 Jul 10;11(7):322. doi: 10.3390/pharmaceutics11070322.